An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm
Interventions:   Procedure: Biospecimen Collection;   Other: Electronic Health Record Review;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
Sponsors:   University of Rochester NCORP Research Base;   National Cancer Institute (NCI);   Roswell Park Cancer Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 7, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments